Semax vs Selank: Research Peptide Comparison

Semax and Selank are often grouped together as synthetic peptides studied in neuropeptide research, which is why they are frequently compared. This article sets out how they differ — in parent peptide, structure and the research areas each appears in — and how each is handled as laboratory material. It is a comparison rather than a pair of profiles; for full background, follow the links to each compound’s guide.

Everything here is factual and educational. It is not guidance for the use of any material in humans or animals, and it makes no claim about safety, performance or outcomes. For how these materials are categorised, see Understanding Research Compounds.

The table below summarises the factual points of difference.

The clearest difference is the parent peptide each derives from. Semax is described in connection with a fragment of ACTH; Selank is described as a synthetic derivative of tuftsin, with a terminal extension added for stability. Both are studied as short synthetic neuropeptides rather than as the natural peptides they relate to. These are descriptions of molecular origin studied in research, not statements about any effect. The detail is in the Semax research overview and the Selank research overview.

Both are seven-residue synthetic peptides, but their sequences and origins differ: one is tied to an ACTH fragment, the other to tuftsin. In each case a stabilising modification is part of the design, which is a common theme among short research peptides. For the notation used to describe such sequences, see Understanding Peptide Sequence Notation.

Both compounds appear in neuropeptide research, and the descriptions here summarise where each is studied rather than any established result. They are commonly examined within that shared area, with the relevant parent-peptide system — ACTH fragment or tuftsin — tending to determine which is referenced. These are areas of published study, not recommended uses.

Both are supplied as lyophilised peptides and handled the same way: confirm the material against its specification on receipt, keep it in the stated storage conditions, and maintain clear records. See Semax Storage & Handling, Selank Storage & Handling and the general Peptide Storage Guidelines.

Because the two are associated with different parent peptides, the relevant material usually follows from the research question rather than from any comparison between them. Work concerning the ACTH-fragment system points toward Semax; work concerning tuftsin points toward Selank. Neither framing implies one compound is superior; they are simply associated with different lines of study.

Both peptides are available in the catalogue with full specifications and storage information: Semax and Selank. The complete range is in the research catalogue, and our approach to material consistency is on the Quality page.

For laboratory research use only. Not for human or animal consumption. The material on this page is educational and factual: it compares how two research compounds are described in published study and handled in the laboratory. It is not guidance for the use of any material in humans or animals, and nothing here should be read as a claim about safety, performance or outcomes. Where a product specification is provided with a material, that document is the definitive reference and takes precedence over any general information given here.